Production (Stage)
Devonian Health Group Inc.
DVHGF
$0.18
$0.036225.17%
OTC PK
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -16.60% | 38.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.60% | 38.57% | |||
| Cost of Revenue | -24.91% | 44.07% | |||
| Gross Profit | 3.16% | 27.04% | |||
| SG&A Expenses | 17.37% | -16.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -2.65% | -2.59% | |||
| Total Operating Expenses | -13.89% | 23.30% | |||
| Operating Income | -112.47% | 140.98% | |||
| Income Before Tax | -2,394.37% | 133.15% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,008.30% | 63.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,008.30% | 63.92% | |||
| EBIT | -112.47% | 140.98% | |||
| EBITDA | -82.29% | 166.51% | |||
| EPS Basic | -1,972.73% | 63.33% | |||
| Normalized Basic EPS | -83.33% | 131.58% | |||
| EPS Diluted | -1,972.73% | 63.33% | |||
| Normalized Diluted EPS | -83.33% | 131.58% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 8.02% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||